Q3 2015 13F Holders as of 30 Sep 2015
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
14,763,664
-
Share change
-
+320,897
-
Total reported value
-
$258,061,139
-
Price per share
-
$17.48
-
Number of holders
-
48
-
Value change
-
+$5,443,089
-
Number of buys
-
20
-
Number of sells
-
19
Institutional Holders of LOXO ONCOLOGY INC - COM (LOXO) as of Q3 2015
As of 30 Sep 2015,
LOXO ONCOLOGY INC - COM (LOXO) was held by
48 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
14,763,664 shares.
The largest 10 holders included
Aisling Capital LLC, ORBIMED ADVISORS LLC, NEA Management Company, LLC, RS INVESTMENT MANAGEMENT CO LLC, BVF INC/IL, DEERFIELD MANAGEMENT CO, DRIEHAUS CAPITAL MANAGEMENT LLC, Visium Asset Management, LP, EVENTIDE ASSET MANAGEMENT, LLC, and AXA.
This page lists
48
institutional shareholders reporting positions in this security
for the Q3 2015 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.